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Abstract
Background: Liver fluke infection of livestock causes economic losses of over US$ 3 billion worldwide per annum. The
disease is increasing in livestock worldwide and is a re-emerging human disease. There are currently no commercial
vaccines, and only one drug with significant efficacy against adult worms and juveniles. A liver fluke vaccine is deemed
essential as short-lived chemotherapy, which is prone to resistance, is an unsustainable option in both developed and
developing countries. Protein superfamilies have provided a number of leading liver fluke vaccine candidates. A new form
of glutathione transferase (GST) family, Sigma class GST, closely related to a leading Schistosome vaccine candidate (Sm28),
has previously been revealed by proteomics in the liver fluke but not functionally characterised.
Methodology/Principal Findings: In this manuscript we show that a purified recombinant form of the F. hepatica Sigma
class GST possesses prostaglandin synthase activity and influences activity of host immune cells. Immunocytochemistry and
western blotting have shown the protein is present near the surface of the fluke and expressed in eggs and newly excysted
juveniles, and present in the excretory/secretory fraction of adults. We have assessed the potential to use F. hepatica Sigma
class GST as a vaccine in a goat-based vaccine trial. No significant reduction of worm burden was found but we show
significant reduction in the pathology normally associated with liver fluke infection.
Conclusions/Significance: We have shown that F. hepatica Sigma class GST has likely multi-functional roles in the host-
parasite interaction from general detoxification and bile acid sequestration to PGD synthase activity.
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Introduction
The liver flukes, Fasciola hepatica and Fasciola gigantica are the
causative agents of fasciolosis, a foodborne zoonotic disease affecting
grazing animals and humans worldwide [1]. Liver fluke causes
economic losses of over US$ 3 billion worldwide per annum to
livestock via mortality, reduction in host fecundity, susceptibility to
other infections, decrease in meat, milk and wool production and
condemnation of livers [1]. The disease is increasing in livestock
worldwide with contributing factors such as climate change (warmer
winters and wetter summers supporting larger intermediate mud
snail host populations); fragmented disease management (only
treating sheep not cattle and limiting veterinary interaction);
encouragement of wet-lands; livestock movement; and/or failure/
resistance of chemical control treatments in the absence of
commercial vaccines [1,2]. Fasciolosis is also a re-emerging human
disease with estimates of between 2.4 and 17 million people infected
worldwide [3]. In response, the World Health Organisation have
added fasciolosis to the preventative chemotherapy concept [4].
There are currently no commercial vaccines and triclabenda-
zole (TCBZ) is the most important fasciolicide, as the only drug
with significant efficacy against adult worms and juveniles [5].
Evidence from developed countries where TCBZ has been used
widely exposes the reliance on this drug as an Achilles heel of liver
fluke chemotherapeutic control, with well-established evidence of
drug-resistance [5]. Therefore, TCBZ does not offer a long-term
sustainable option for livestock farmers worldwide. The need for a
liver fluke vaccine is further underscored by the fact that the costs
associated with anthelmintic intervention for fluke control make
short-lived chemotherapy an unsustainable option in developing
countries. Protein superfamily studies in liver fluke have provided
a number of leading vaccine candidates. High quality one-gene
based vaccine discovery research has identified several vaccine
candidates from protein superfamilies that provide significant, but
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often variable protection rates in challenge animal trials against
liver fluke.
For example, Mu class Glutathione transferase (GSTs) have
been widely investigated as vaccine candidates for fasciolosis
[6–9]. The Mu class GSTs have established roles in general
Phase II detoxification of xenobiotic and endogenously derived
toxins in F. hepatica within the host bile environment [10]. The
general detoxification role is supported by GSTs contributing to
4% of the total soluble protein in F. hepatica, with a widespread
tissue distribution. Proteomics and EST sequencing approaches
have now delineated what members of the GST family are
expressed in F. hepatica and two new classes of GST, Sigma and
Omega, have been uncovered [11]. In the related trematode,
Schistosoma mansoni, the Sigma class GST (Sm28) has generally
shown more robust protection in vaccine trials against
schistosome infection [12], than the F. hepatica Mu GSTs
against F. hepatica infection.
Sigma class GSTs, unlike Mu Class GSTs, have been
characterized as GSH-dependent hematopoietic prostaglandin
synthases responsible for the production of prostaglandins in
both mammals and parasitic worms [13–18]. Prostaglandins
have been extensively studied in mammals and are shown to be
involved in a range of physiological and pathological responses
[19–23]. Parasite-produced prostaglandins may be involved in
parasite development and reproduction as well as the modula-
tion of host immunity, allergy and inflammation during
establishment and maintenance of a host infection [16,24–28].
The host protection success of Sigma GST based vaccinations in
schistosomiasis may therefore be related to neutralising specific
functions in host-parasite interplay, such as prostaglandin
synthase activity.
In this manuscript we follow four work pathways to functionally
characterise the newly identified Sigma GST from F. hepatica. 1)
We confirm its designation as a Sigma class GST using substrate
profiling, 2) we assess prostaglandin synthase activity and its effect
on host immune cells, 3) we localise the Sigma GST within adult
fluke and between ontogenic stages and 4) assess its potential as a
vaccine candidate.
Materials and Methods
Sequence analysis
GST proteins representative of recognised GST superfamily
classes were obtained from European Bioinformatics Institute
Interpro database (http://www.ebi.ac.uk/ interpro/), and from
non-redundant databases at NCBI (http://www.ncbi.nlm.nih.
gov/). A mammalian and a helminth or invertebrate GST
sequence were selected for each GST class where available.
Sequences were aligned via ClustalW program [29] in BioEdit
Sequence Alignment Editor Version 7.0.5.2. [30] and sequence
identity matrices produced from multiple alignments. Phylogenetic
bootstrap neighbour-joining trees were produced as PHYLIP
output files in ClustalX Version 1.83 [31] according to the
neighbour-joining method of Saitou and Nei [32]. ClustalX
default settings for alignments were accepted using the GONNET
protein weight matrices with PHYLIP tree format files viewed
within TREEVIEW [33].
Recombinant Fasciola hepatica glutathione transferase
Sigma class (rFhGST-S1) production
Full-length cDNA for FhGST-S1 was available in the form of
an expressed sequence tag (EST) clone Fhep24h03, details of
which can be obtained from the previously published Sigma class
GST [11] and is identical to the submitted GenBank accession
No. DQ974116.1 (NCBI http://www.ncbi.nlm.nih.gov/).
FhGST-S1 was amplified via PCR using the following primer
pair: rFhGST-S1 forward primer, 59 GGAATTCCATATGGA-
CAAACAGCATTTCAAGTT 39;rFhGST-S1 reverse primer, 59
ATAAGAATGCGGCCGCCTAGAATGGAGTTTTTGCAC-
GTTTTTT 39. Restriction enzyme sites (in bold type and
underlined) for NdeI (forward primer) and NotI (reverse primer)
were included so that the entire ORF could be directionally cloned
into the pET23a (Novagen) vector. Recombinant protein was
produced in Escherichia coli BL21(DE3) cells (Novagen).
Protein purification of rFhGST-S1 and native F. hepatica
GSTs
rFhGST-S1 protein was purified according to the glutathione
affinity chromatography method of Simons and Vander Jagt [34]
from transformed E. coli cytosol following protein expression.
Native GSTs were purified from F. hepatica soluble cytosolic
supernatants as previously described [11]. Purity of rFhGST-S1
was assessed by electrospray ionisation (ESI) mass spectrometry,
sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-
PAGE) and 2DE according to LaCourse et al. [35].
Substrate profiling of Sigma GST
A range of model and natural substrates (see Table 1 for details)
were used to profile the Sigma GST. A number of ligands were
also assessed for their ability to inhibit GST activity with 1-chloro-
2, 4-dinitrobenzene (CDNB) as the second substrate [36]. Values
were reported as the concentration of inhibitor required to bring
GST specific activity to 50% of its original activity (IC50). At least
six different inhibitor concentrations were used in each IC50
determination in triplicate. Inhibitors were pre-incubated for
5 minutes prior to starting reactions. IC50 values were estimated
graphically [37].
Prostaglandin synthase activity was assessed via an adapted
method based upon those of Sommer et al. [26] and Meyer et al.
[16,38], with extraction modifications based upon Schmidt et al.
[39]. In brief, reactions were performed in glass vials in 2 mM
sodium phosphate buffer, pH 7.4, containing 10 mM glutathione,
Author Summary
Combating neglected parasitic diseases is of paramount
importance to improve the health of human populations
and/or their domestic animals. Uncovering key roles in
host-parasite interactions may support the vaccine poten-
tial portfolio of a parasite protein. Fasciola hepatica causes
global disease in humans and their livestock but no
commercial vaccines are available. Members of the Sigma
class glutathione transferase (GST) family have long been
highlighted as vaccine candidates towards parasitic flat-
worms. To this end, a Sigma class GST is currently
undergoing phase II clinical trials to protect against
infection from the schistosomes. In this study we
characterise the protein from F. hepatica following four
work pathways that 1) confirm its designation as a Sigma
class GST using substrate profiling, 2) assess prostaglandin
synthase activity and its effect on host immune cells, 3)
localise the Sigma GST within adult fluke and between
ontogenic stages and 4) measure its potential as a vaccine
candidate. The work presented here shows F. hepatica
Sigma class GST to have key host-parasite roles and we
suggest, warrants further investigation for inclusion into
vaccine formulations.
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50 mM NaCl, 0.5 mM tryptophan, 1 mM hematin, 1 U COX-1
enzyme, 100 mM arachidonic acid (All Sigma, UK. COX-1
[C0733]) and rFhGST-S1 at final concentration ranges of 0.1–
100.0 mg/ml. Negative control reactions lacking either GST or
COX-1 were also prepared. Reactions were incubated for 5–
10 min in a water bath at 37uC. This was followed by 4 minutes
incubation at 25uC in a shaking water bath. Prostaglandins were
extracted by adding 860 mL of ice-cold ethyl acetate. Reactions
were vortexed for 30 s then centrifuged briefly at 10,0006g at 4uC
for 2 min. The upper ethyl acetate layer was retained and solvent
was evaporated under a nitrogen stream at 45uC. The remaining
residue was reconstituted in 50 ml of methanol/water/fomic acid
(25:75:0,1) mix at pH 2.8 and stored at 280uC until ready for
mass spectrometry analysis. Standards of prostaglandins D2, E2
and F2a (Cayman, Ltd) were also prepared in methanol/water/
formic acid mix for analysis.
Prostaglandin detection
The nano LC-MS analyses were performed using a Waters Q-
Tof micro mass spectrometer (Waters) coupled to a LC-Packings
Ultimate nano LC system (Dionex). The pre-column used was a
LC Packings C18 PepMap 100 and the nano LC column used was
a LC Packings 15 cm PepMap 100 C18 (both Dionex). Samples
were loaded on the pre-column with mobile phase A (25%
methanol with 0.1% formic acid added). Loading flow rate was
0.03 ml/min for 6 min. The samples were eluted on to the nano
LC column using mobile phases B (60% acetonitrile) and C (100%
methanol). A typical gradient profile was 100% B to 100% C in
10 min (flow rate of 0.2 ml/min) with the column held at 100% C
for 1 hour. The mass spectrometer was operated in the negative
ion nano electrospray mode with a source temperature of 80uC
and capillary voltage 2.8 kV. The scan range was 40 to 400 Da for
1.5 s.
Liver fluke extract and excretory/secretory (ES) product
preparation
F. hepatica adults were collected, cultured in vitro for 4 h and the
ES products collected and prepared as previously described [40].
Newly excysted juveniles (NEJ) were excysted from metacercariea
in vitro and cultured in Fasciola saline for 4 h post excystment as
previously described [41]. F. hepatica (adult and NEJ) soluble
fractions were obtained by homogenisation of frozen fluke at 4uC
in a glass grinder in lysis buffer (20 mM KHPO4, pH 7.0, 0.1%
Triton-X100 and a cocktail of protease inhibitors [Roche,
Complete-Mini, EDTA-free]). Homogenates were centrifuged at
100,0006 g for 1 h at 4uC. Supernatants were considered as the
soluble cytosolic fraction. Cytosolic protein extracts were treated
and resolved by 2DE as described previously [11]. F. hepatica eggs
were isolated, cultured and protein extracted as previously
described [42].
Western blotting
Recombinant F. hepatica Sigma GST (rFhGST-S1), and native
F. hepatica S-hexylGSH-affinity purified GST samples (and
human/rat recombinant PGD-synthase) were subjected to stan-
dard SDS-PAGE and 2DE, electro-transferred to membranes
[43,44] and western blotted with a polyclonal antibody (1:20,000
dilution) raised in rabbits to the recombinant F. hepatica Sigma
GST by Lampire Biological Laboratories, USA. Membranes were
also probed with Mu class GST antibody (represented by the anti-
Schistosoma japonicum GST26 Mu class antibody [1:1,000 dilution]
and an anti-rat PGD-synthase antibody [1:1,000 dilution],
Pharmacia-Biotech 27-4577). F. hepatica eggs, NEJs (somatic and
ES preparations) and adults (somatic and ES preparations) were
subjected to SDS-PAGE and also electro-transferred as described
above and probed with the polyclonal antibody raised in rabbits to
the recombinant F. hepatica Sigma GST. All western blots were
developed as described previously [11].
Immunolocalisation studies
F. hepatica Sigma class GST (FhGST-S1) was detected by
immunohistology in tissue sections of whole adult F. hepatica
extracted from bile ducts of sheep liver and also in situ from
sections of liver.
Staining for FhGST-S1 was performed on formalin-fixed and
paraffin-embedded tissue sections according to the method
described previously [45]. Sections were washed in Tris-buffered
saline (TBS; 0.1 M Tris-HCl with 0.9% NaCl [pH 7.2]), treated
with 0.05% (w/v) protease (type XXIV, bacterial: Sigma) in TBS
for 5 min at 37uC for antigen retrieval, before three further 5 min
washes in ice-cold TBS. Following TBS washes, sections were
incubated for 10 min in 50% (v/v) swine serum in TBS followed
by incubation for 15–18 h at 4uC in rFhGST-S1 polyclonal
antibody (diluted at 1:500 in 20% swine serum in TBS). Sections
were again washed in TBS before further incubation at ambient
temperature (approximately 20uC+/23uC) with anti-rabbit per-
oxidise anti-peroxidase (PAP; diluted at 1:100 in 20% swine serum
in TBS). Following washes with TBS, sections were incubated,
with stirring, for 10 min, with 3,3-diaminobenzidine tetrahy-
drochloride (DAB; Fluka, Buchs, Switzerland) with 0.01% v/v
hydrogen peroxide in 0.1 M imidazole buffer pH 7.1, before
counterstaining with Papanicolaou’s hematoxylin for 30 s. Sec-
tions were then rinsed, dehydrated in alcohol, cleared in xylene,
and mounted. Consecutive sections from each tissue were used as
negative controls in which the rFhGST-S1 polyclonal antibody
was replaced by TBS.
Induction of prostaglandin from dendritic cells
Animals. C57BL/6 mice were purchased from Harlan Ltd
(UK) and TLR4KO (on a C57BL/6 background) bone marrow
cells were a gift from Professor Padraic Fallon (Trinity College
Dublin, Ireland). All mice were maintained according to the Irish
Department of Children and Health.
Cell culturing and cytokine analysis. Bone marrow-
derived immature dendritic cells (DCs) were prepared by culturing
bone marrow cells isolated from the femurs and tibia of C57BL/6j
and TLR42/2 mice in complete RPMI 1640 (cRPMI; 5% [v/v]
heat inactivated Fetal Calf Serum [FCS] [30 mins at 60uC],
100 U/ml penicillin, 100 mg/ml streptomycin, 2 mM L-glutamine
and 50 mM 2-mercaptoethanol) with recombinant mouse GM-
CSF (20 ng/ml; R&D Systems), at 37uC. On days 3 and 6 of
culture, fresh medium with GM-CSF (20 ng/ml) was added to the
cells. On day 8, cells were harvested, counted and stained with
CD11c (Caltag Laboratories) for analysis by flow cytometry to
determine purity (.90%). J774 cells and RAW264.7, murine
macrophage cell lines were cultured in cRPMI 1640 medium
containing 10% (v/v) FCS. All cells were used to conduct
experiments when they reached ,90% confluence.
For all experiments, cells were seeded into 24-well plates (Nunc)
at 106/ml in complete RPMI 1640 except for DCs where GM-
CSF (5 ng/ml) was also added. Cells were treated with medium
only, rFhGST-S1 (10 mg) or LPS (Alexa; 100 ng/ml) for 18 h.
Levels of total prostaglandin (PG), prostaglandin E2 (PGE2) and
prostaglandin D2 (PGD2) were measured using the Cayman
competitive EIA. The values were calculated using free data
analysis software available at www.caymanchem.com/analysis/
eia. Data are presented as the mean 6 SEM following subtraction
Sigma Class Glutathione Transferase of F. hepatica
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of medium controls and are representative of two separate
experiments. Prior to experimentation, rFhGST-S1 was assessed
for endotoxin (i.e. LPS) contamination using the Pyrogene
endotoxin detection system (Cambrex).
Vaccination Strategy
Experimental design. Nineteen 5-month old, Malaguen˜a
breed goats were used for a vaccine trial. The animals were free of
parasitic and infectious diseases as indicated by fecal analysis and
absence of clinical signs. Group 1 (n = 10) were immunized with
two subcutaneous injections of 100 mg of rFhGST-S1 in 1 ml of
Quil A in 1 ml of PBS each injection separated by 4 weeks. Group
2 (n = 9) served as an infected control and was immunized at the
same time with 1 ml of Quil A in 1 ml of PBS. Twelve weeks after
the first immunization, animals were orally infected with 100 F.
hepatica metacercariae of bovine origin. Three animals from each
group were killed at 7, 8 and 9 days post-infection to study hepatic
changes and host response during the early stages post-infection;
the remaining animals (7 and 6 goats per group) were killed 15
weeks after infection to study fluke burdens, fecal egg counts and
hepatic lesions. All goats were sacrificed by intravenous injection
of thiobarbital. The experiment was approved by the Bioethical
Committee of the University of Cordoba (N. 7119) and it was
carried out according to European (86/609/CEE) and Spanish
(RD 223/1988) directives for animal experimentation.
Fluke burdens and morphometrics. At necropsy, gallblad-
ders and bile ducts were opened and flukes recovered. Llivers were
cut (,1 cm pieces) and washed in hot water to collect the
remaining flukes. Flukes were counted, measured and weighed.
Fecal egg counts. Sedimentation techniques at 12 and 13
weeks after infection using four grams of feces were conducted to
give eggs per gram (EPG).
Pathological assessment. At necropsy livers were photo-
graphed by the visceral and diaphragmatic aspects for gross
pathology evaluation as described previously [46]. Gross hepatic
lesions were scored as: absent [2]; mild [+] (less than 10% of
hepatic surface affected); moderate [++] (10–25% of hepatic surface
affected); severe [+++] (25–50% of hepatic surface affected) and
very severe [++++] (more than 50% of hepatic surface affected).
Tissue samples were collected from the left (6 samples) and right (2
samples) hepatic lobes, fixed in 10% buffered formalin and
embedded in paraffin wax. Tissue sections (4 mm) were stained
with haematoxylin and eosin (HE) for the histopathological study.
Specific IgG response. Specific IgG anti-rFhGST-S1were
measured using the ELISA method as described previously [46]. A
total of 10 mg/ml of rFhGST-S1 was used to coat microtitre plates,
100 ml/well of goat sera diluted in blocking buffer and rabbit anti-
goat IgG peroxidase conjugated (whole molecule - Sigma) diluted
in blocking buffer at 1:10000. Serum pools were from ten
experimentally infected goats and ten uninfected goats as positive
and negative controls, respectively. All samples were analysed in
duplicate. Results were expressed as antibody titre (Log10).
Results
Expression, purification and characterisation of rFhGST-
S1
Aligning Sigma class GSTs of trematodes shows the extent of
identity and similarity across this class of GSTs (Figure S1). An
amino acid sequence comparison of FhGST-S1 with other
trematode GSTs places FhGST-S1 into the Sigma class of GSTs,
with identities averaging approximately 45%. Comparison with
the most closely matching mammalian GSTs shows sequence
identities averaging only approximately 28% (Table S1). Despite
phylogenetic neighbour-joining trees place mammalian and
trematode GSTs within the same broad Sigma class (Figure S1)
there remains a distinct separation of the trematode and
mammalian clusters.
Full sequence length recombinant F. hepatica Sigma Class GST
(rFhGST-S1) was shown to be purified to a high level from
transformed E. coli cytosol following expression yielding 57.3 mg of
rFhGST-S1 from a 1 litre culture of BL21 (DE3) cells. Purity was
judged by the presence of a single band upon SDS-PAGE at the
estimated size and a dominating single peak via ESI MS at the
precise calculated theoretical mass for the complete protein
sequence (Figure 1). Analysing this fraction by 2D SDS-PAGE
revealed a single protein resolving into 3 protein spots. Western
blotting of the 2DE profile with anti-rFhGST-S1 antibody
confirmed all 3 resolved protein spots as rFhGST-S1 (2DE and
western blot data not shown). No recognition was seen probing the
3 spots with an anti-Mu class antibody.
rFhGST-S1 was produced as an active protein, displaying
significant enzymic activity towards the model GST substrate 1-
chloro-2,4-dinitrobenzene (CDNB) and a range of substrates
commonly used to characterise GSTs (Table 1). F. hepatica GST is
very similar in terms of its enzymatic profile to the GST of S.
Figure 1. Expression and purification of recombinant FhGST-
S1. A) ESI mass spectrum of the GSH-affinity purified rFhGST-S1
showing the MW of rFhGST-S1 at 24536.3960.77 Da. B) SDS-PAGE gel
of the expression and purification of rFhGST-S1. Lane 1. E. coli total
cytosolic protein. Lane 2. GSH-affinity purified recombinant rFhGST-S1
protein. Ran on 12.5% SDS PAGE and coomassie blue stained.
doi:10.1371/journal.pntd.0001666.g001
Sigma Class Glutathione Transferase of F. hepatica
www.plosntds.org 5 May 2012 | Volume 6 | Issue 5 | e1666
japonicum currently undergoing clinical vaccine trials. FhGST-S1
also displays higher glutathione-dependent lipid peroxidase
activity compared to both Sm28GST and Sj26GST [47].
Interestingly, ligand inhibition studies on rFhGST-S1 showed
the enzymic activity of rFhGST-S1 with CDNB was inhibited by
the major pro-active form of the main liver fluke drug
Triclabendazole. The sulphoxide derivative (TCBZ SO) gave an
IC50 (50% enzyme inhibition) of 5765 mM (5 replicates). Bile
acids, potentially natural ligands for liver fluke tegumental
associated proteins in the host bile environment, were also assessed
for activity inhibition. The rFhGST-S1 interacted with all three
bile acids tested using five replicate assays: Cholic acid (IC50
302673 mM); Deoxycholic acid (IC50 223621 mM) and Cheno-
deoxycholic acid (IC50 6469 mM).
Previous studies on the Sigma class GSTs from both mammals
and helminth parasites have revealed a capacity to synthesise
Prostaglandin D2 (PGD2) and PGE2. Since prostaglandin synthase
activity may be a conserved role of Sigma class GSTs, we also tested
the ability of rFhGST-S1 to synthesise prostaglandin eicosanoids
using a coupled assay with COX-1. COX-1 catalyses the conversion
of arachidonic acid to the H2 form before the prostaglandin isomer
is converted to either the D or E form. Nano-LC/MS analysis
enabled us to detect the presence of both PGD2 and PGE2 in the
assay mixture with the PGD2 form being the more abundant of the
two prostanoids (Figure 2). While some PGE2 in the mixture could
have arisen from rapid degradation of the unstable PGH2, nano-
LC-MS was unable to detect either PGD2 or PGE2 in negative
control reactions lacking either COX-1 or GST. The rFhGST-S1
catalyses PGD2 formation in a concentration-dependent manner as
previously described for rOvGST-1 [26]. PGD2 was also detected
in coupled assays with rFhGST-S1 and COX-1 using an Enzyme
Immno Assay (EIA) detection kit (Cayman) and showed similar
results (results not shown).
Tissue localisation of Sigma GST
FhGST-S1 was first identified in adult liver fluke in S-hexyl-GSH
affinity isolated fractions of cytosol [11]. Western blots confirmed
the presence of FhGST-S1 in NEJs and adult flukes and further
enabled us to identify the Sigma GST in relative abundance in egg
extracts, suggesting that it may play a metabolic role in
embryogenesis/reproduction (Figure 3). Western blot analyses
demonstrate that FhGST-S1 is consistently expressed during the
course of in vitro parasite embryonation (days 1–9, only data for days
2, 7 and 9 shown in Figure 3). In contrast, immunoblot analysis of
freshly voided (day 0) eggs reveals that expression of the Sigma class
GST is greatly reduced at the time of voiding from the host
(Figure 3). However, immunolocalisation studies of adult parasites
revealed an abundance of FhGST-S1 in the vitelline cells and eggs,
emphasising the likely importance of this enzyme in egg formation
and development. Some staining was also found in the parasite
parenchyma and tegument, also suggesting a role at the host-
parasite interface (Figure 4). Indeed, FhGST-S1 was detected in ES
products of adult fluke cultured in vitro (Figure 3) suggesting that the
protein could, in principle, come into contact with the host immune
system as it is released from the tegument during tegumental
turnover and sloughing of the fluke body surface.
Figure 2. Detection of prostaglandin synthase activity of rFhGST-S1 via a mass spectrometry approach. A coupled assay with rFhGST-
S1 and COX-1 catalyses the conversion of arachidonic acid to the H2 form before the prostaglandin isomer is converted to either the D or E form.
Nano-LC/MS analysis allowed detection of both PGD2 (A) and PGE2 (B) in the assay mixture with the PGD2 form being the more abundant of the two
prostanoids (C). Boxed figures above peaks show the fragmentation ions specific to detection of PGD2 (a) and PGE2 (b) according to the method of
Schmidt et al. [39].
doi:10.1371/journal.pntd.0001666.g002
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Influence of rFhGST-S1 on prostaglandin synthesis in
host immune cells
rFhGST-S1 exhibited prostaglandin synthase activity producing
PGE2 and PGD2. In addition, it has been shown previously that
rFhGST-S1 activates DCs in vitro [48]. Therefore, an attempt to
determine if rFhGST-S1 could induce the secretion of total
prostaglandin, PGE2 and PGD2 from DCs was performed. Prior
to experimentation, endotoxin levels in rFhGST-S1 were assessed
and were similar to that of the media alone. Both of which were
below the lower limit of detection (,0.01 EU/ml). When
examining prostaglandin induction DCs stimulated with
rFhGST-S1 secreted total prostaglandin and PGE2 (DC (WT);
Figure 5) but not PGD2 (data not shown). Since it has been
previously determined that the activation of DCs by rFhGST-S1
was dependent upon TLR4 [48] we repeated the experiment in
DCs from TLR4KO mice and in keeping with previous findings
demonstrated that the secretion of total prostaglandin and PGE2
by rFhGST-S1 was significantly reduced in the absence of the
TLR4 receptor (DC (TLR4KO); Figure 5). rFhGST-S1 was then
further assessed for its potential to induce prostaglandin secretion
from macrophages by exposing two macrophage cell lines with
rFhGST-S1. After 18 hours the levels of total prostaglandin,
PGE2 and PGD2 were measured. In this assay, both macrophage
cells lines stimulated with rFhGST-S1 secreted total prostaglandin,
PGE2 and PGD2 (Figure 6). However, the levels secreted by J744
cell line were higher when compared to the amount secreted by
RAW264.7 cell line. In these experiments we included medium
only as a negative control and LPS as a positive control. In all
experiments the levels of prostaglandin in response to rFhGST-S1
was comparable to the levels secreted in responses to LPS.
Assessment of goat vaccinations with rFhGST-S1
challenged with F. hepatica
Following the completion of the vaccine trial, liver fluke were
recovered and the livers scored. The resulting data is summarised
in Table 2. When assessing fluke burdens, length, weight and fecal
egg counts, no significant differences between rFhGST-S1
immunised and Quil A immunised groups were observed. Despite
this lack of significance, at 7–9 days post-infection (dpi) the
number of gross hepatic lesions appeared reduced in rFhGST-S1
immunised groups compared to the Quil A control group. At 15
weeks post-infection (wpi), a similar outcome is observed. Liver
hepatic lesion scoring appeared to show reductions in the severity
of damage occurred in the rFhGST-S1 immunised group
compared to the Quil A only group, despite no significant
differences in the aforementioned morphometric data.
Microscopically, at 7–9 dpi animals from the Quil A group
showed tortuous necrotic tracts surrounded by a scarce inflam-
matory infiltration with occasional eosinophils (Figure 7A). Older
necrotic areas were surrounded by macrophages, epithelioid cells
and multinucleate giant cells and lymphocytes. Some migrating
larvae were found in the liver parenchyma without inflammatory
infiltrate associated to them. In goats immunised with rFhGST-S1
smaller necrotic areas associated to a heavy infiltration of
eosinophils (Figure 7B) were seen. Unlike the Quil A immunised
group, all migrating larvae found were surrounded by a heavy
infiltration of eosinophils.
A significant increase of IgG anti-rFhGST-S1 was observed two
weeks after vaccination with a strong increase after the second
injection at week 4 in immunised animals (Figure 8). The Quil A
control group did not show any specific IgG response until 2 weeks
after infection. Specific IgG titres increased during infection in
both groups, but they were consistently higher in the immunised
group throughout the duration of the the experiment.
Discussion
Previous studies have highlighted the importance of parasite
GSTs, including Sigma class GSTs, in host-parasite interactions
and as potential vaccination candidates. With this in mind, we
have studied the relatively newly identified Sigma class GST from
F. hepatica to both enhance our understanding of this important
enzyme in Fasciola and the Sigma class of GSTs as a whole.
Alignments and phylogenetics classified FhGST-S1 alongside
trematode and mammalian Sigma class GSTs, yet there remains a
Figure 3. Western Blotting localising FhGST-S1 in embryonating eggs, NEJs, adults and adult ES products. 10 mg of each protein
sample was resolved through 14% SDS PAGE and electrophoretically transferred to Hybond C nitrocellulose membrane. Membranes were amido
black stained membrane to assess protein transfer (A) Membranes were incubated with anti-FhGST-S1 antibody diluted 1:30,000 and developed
using the BCIP/NBT liquid substrate system according to manufacturer’s instructions (B). 1: Low Molecular Weight Marker (GE Biosciences); 2: Day 0
Egg; 3: Day 2 Egg; 4: Day 7 Egg; 5: Day 9 Egg; 6: NEJ Somatic Sample; 7: Adult Somatic Sample; 8: NEJ ES Products; 9: Adult ES Products; 10: Uninfected
Galba truncatula –ve Control.
doi:10.1371/journal.pntd.0001666.g003
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distinct divide between the parasites and their hosts, a phenom-
enon also observed for the recently reclassified ‘Nu’ class of GSTs
from nematodes [49]. Therefore, it may be that trematode GSTs
are sufficiently distinct to support a sub-classification within the
broad Sigma class. The distinction of FhGST-S1 from fasciolosis
host Sigma class GSTs enhances its potential as a therapeutic
target.
Substrate activity profiling of rFhGST-S1 using model sub-
strates showed the enzyme to have comparable activity to other
trematode Sigma class GSTs such as Sm28GST [47]. However,
rFhGST-S1 exhibits relatively high GSH-conjugating activity
towards the potentially natural reactive aldehyde, 4-hydroxy-
nonenal (4-HNE) toxin and high GSH-dependent peroxidase
activity towards the tested lipid peroxides which includes the
endogenous substrate linoleic acid hydroperoxide. 4-HNE is the
major aldehydic end-product of lipid peroxidation that is involved
in signalling of host immune cells leading to apoptosis of T- and B-
cells [50].
Assessing the inhibition of rFhGST-S1 activity with CDNB
revealed that both bile acids and the flukicide TCBZ appear to
bind to the enzyme. In particular, the interaction of the bile acid
cholate with rFhGST-S1 is approximately ten fold higher than
GSTs from the sheep intestinal cestode Moniezia expansa [51]. Host
bile acids are known as triggers of physiological processes in
trematodes including Fasciola sp. [52,53]. Therefore, molecular
interaction of bile acids with FhGST-S1 warrants further
investigation especially, given that FhGST-S1 is localised to near
the body surface of the fluke, where it could potentially bind
cholate and other free bile acids found in abundance in host bile
(cholate is found at approximately 100 mM in sheep bile) [54].
The hydroxy-TCBZ SO levels in the bile have been shown to be
in excess of 100 mM [55] thus, the IC50 of 5765 mM for TCBZ
SO suggests the abundant FhGST-S1 could be involved in TCBZ
response in phase III sequestration based detoxification. This
finding warrants further investigation to understand the role of
FhGST-S1 in TCBZ action or detoxification.
Sigma class GSTs from both parasites and mammals have been
known to exhibit prostaglandin synthase activity. To this end, the
Sigma GST from F. hepatica shares a high sequence identity with
recognised Sigma class GSTs with prostaglandin synthase activity,
including rOvGST-1 from the filarial parasite, Onchocerca volvulus.
Using a coupled assay with COX-1 we have shown that rFhGST-
S1 is capable of synthesizing both PGD2 and PGE2, with PGD2
being the predominant prostanoid. Parasite-derived eicosanoids,
including prostaglandins, are known to be important in the
establishment of parasitic infection and the survival and prolifer-
ation within the host. Therefore, eicosanoids produced by parasitic
helminths may play a role in pathophysiological changes during
helminth infections. For example, chronic fasciolosis is associated
with fever and changes in liver biochemistry, both of which could
be associated with parasite-derived eicosanoids thromboxane B2
(TXB2), PGI2, PGE2 and leukotriene B4 (LTB4), detected in the
ES products and homogenates of adult F. hepatica worms [56]. In
addition, the migration of host epidermal Langerhans cells, which
play a key part in immune defence mechanisms, has been shown
to be inhibited by parasite-derived PGD2 in the Schistosoma mansoni-
mouse model of human infection, thus allowing schistosomes to
manipulate the host immune system [57]. Earlier studies have
revealed the presence of eicosanoids produced by S. mansoni
cercariae which could also play a role in establishment of
infections through loss of the cercarial tail following penetration
of the skin [58]. It therefore seems likely that prostaglandins
synthesised via FhGST-S1 will have a role in establishing the
infection within the host.
In general, prostaglandins and eicosanoids have potent biolog-
ical activities in reproduction. For example in the zebrafish egg,
high levels of PGE2 were seen post fertilisation coupled with high
PGD2 synthase transcript levels during the early stages of egg
Figure 4. Images of FhGST-S1 localisation within F. hepatica tissue. A) Anti-F. hepatica FhGST-S1 immunohistochemical stain of a fluke in
cross section within the host sheep liver bile duct. Heavily stained eggs (E) are shown released from the fluke into the bile duct in the top left-hand
corner. Brown stained areas show the presence of FhGST-S1 proteins. The lack of staining in the host liver (L) highlights the specificity of the antibody.
Composite picture. B) Enlarged region of A showing the intense anti-F. hepatica FhGST-S1staining in the voided eggs (E). The spines (S) present in the
tegument (T) can be clearly distinguished by their lack of FhGST-S1 presence. C–E) Cross sections of a F. hepatica adult highlighting staining of FhGST-
S1 in the parenchyma (P), musculature (M),the tegument (T), basal membrane (Bm) and most intensely in the vitelline cells (V) and developing eggs
(DE). No staining can be seen in the tegumental spines (S), testes (T) or the intestinal caecum (IC).
doi:10.1371/journal.pntd.0001666.g004
Figure 5. rFhGST-SI stimulates the production total prosta-
glandin and PGE2 from dendritic cells (DCs) in a TLR4
dependent manner. DCs derived from the bone marrow from C57BL/
6j mice were cultured in vitro with medium, rFhGST-S1 (10 mg/ml) or LPS
(100 ng/ml) for 18 hours, and the production of total prostaglandin, PGE2
and PGD2 (data for PGD2 not shown) released into supernatants
determined by competitive EIA. Data are presented as the mean 6 SEM
following subtraction of medium controls and are representative of two
experiments. WT – wild type; TLR4KO – Toll like receptor 4 knock out.
doi:10.1371/journal.pntd.0001666.g005
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development concomitant with an exponential decrease of PGD2
levels over the next 120 h post fertilisation [59]. However, in F.
hepatica, eggs in gravid adults are released in an immature state in
the bile duct, where they pass to the external environment via the
host’s excretory system and complete embryogenesis ex-host.
Therefore, FhGST-S1 may have a secondary, or indeed primary,
function in egg development and embyrogenesis. A role in egg
development is further supported by proteomic studies of F.
hepatica ontogenic stages which reveal the presence of FhGST-S1
in eggs ([42] and the current study).
FhGST-S1 appears to be highly abundant in eggs with western
blotting showing FhGST-S1 to be constitutively expressed, despite
its association with a large spot consisting of multiple co-migrating
proteins unresolved via 2DE (for association see [42]). Immuno-
localisation studies revealed that FhGST-S1 is closely associated
with vitelline cells of mature adult worms. Given the importance of
PGs in reproduction, we hypothesize that PG synthase activity
exhibited by rFhGST-S1 contributes to developmental cues during
egg formation. Interestingly, no FhGST-S1 was seen in day 0, un-
embryonated, eggs by western blotting yet in situ immunlocalisa-
tion showed freshly voided eggs, equivalent to day 0 eggs, to
contain copious amounts of FhGST-S1. While it is most likely that
FhGST-S1 is present in day 0 eggs, albeit at a reduced expression,
the discrepancy seen between the two techniques is probably
related to the antibody dilutions used for each method; in total a
40-fold difference in favour of immunolocalisation.
FhGST-S1 was also identified in both NEJs and adult worms
using western blotting. This finding emphasises the multi-
functionality of FhGST-S1, where in NEJs egg productions is
not yet in process, suggesting its main function is in PG synthesis
for host modulation or as a detoxification enzyme. In the adult
worm, FhGST-S1 could also be localised, to a smaller extent, in
the parenchyma and tegument. Given the high activity of FhGST-
S1 towards the toxic 4-HNE and to lipid hydroperoxides this
suggests a detoxification role at the host-parasite interface.
With near surface expression of FhGST-S1, in the parenchyma
and tegument, there is the potential for this enzyme to be readily
released into the host environment. Indeed, we have identified
FhGST-S1 in the ES products of adult worms. With this in mind,
previous studies have highlighted the importance of parasite Sigma
class GSTs in immunomodulation of the host immune response.
This includes our recent study implicating rFhGST-S1 in chronic
inflammation through the activation of dendritic cells (DCs) [48].
While active rFhGST-S1 was able to induce levels of IL-12p40
and IL-6 cytokines in DCs in a dose-dependent manner, the
previously described F. hepatica Mu-class GSTs failed to induce any
cytokine secretion. Since denatured rFhGST-S1 also failed to
induce any cytokines in DCs, activation of DCs is likely related to
the structure and activity of the enzyme. However, inhibition of
nitric oxide production, involved in driving a Th2 immune
response, may also be a contributing factor in skewing the host
response to fasciolosis [60].
F. hepatica infections are associated with a T-helper-cell type 2
(Th2) immune response dominating during the chronic phases of
infection [61], but pro-inflammatory responses are suppressed
[62]. Suppression of allergic responses during chronic parasitic
worm infections has a mutually beneficial effect on the parasites’
proliferation and the hosts’ survival. Prostanoids, including PGD2,
are important in mediating these allergic inflammatory responses.
While generally regarded as pro-inflammatory molecules, these
important lipid molecules are also involved in mediating anti-
inflammatory responses [63]. Helminth-derived molecules are
thought to be involved in driving the Th2 response stereotypical of
parasitic worm infections. DC and macrophage cell cultures
Figure 6. rFhGST-SI stimulates the production PGE2 and PGD2
from the macrophage cell lines J774 and RAW264.7. J744 and
RAW264.7 macrophage cell lines were cultured in vitro with medium,
rFhGST-S1 (10 mg/ml) or LPS (100 ng/ml) for 18 hours, and the
production of total prostaglandin, PGE2 and PGD2 released into
supernatants determined by competitive EIA. Data are presented as the
mean 6 SEM following subtraction of medium controls and are
representative of two experiments.
doi:10.1371/journal.pntd.0001666.g006
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exposed to rFhGST-S1 showed elevated levels of Th2 cytokines
after 24 h [48]. In this study, the effects of rFhGST-S1 exposure
onprostanoid synthesis in host immune cells was investigated. The
results of which show the stimulation of PGD2 and PGE2 in both
DCs and macrophage cell lines suggesting FhGST-S1 is one such
helminth derived molecule capable of driving the Th2 response.
As we have shown FhGST-S1 to have key roles in F. hepatica,
both in NEJs and adult worms, coupled with the near surface
expression and release of the enzyme via the ES products, we
assessed the potential of FhGST-S1 to be used as a vaccine
candidate. This was especially poignant given that the S. mansoni
Sigma GST homologue (Sm28) is in phase II clinical trials [12].
Unfortunately, the current goat based vaccine trial did not show
any significant differences in fluke burdens between the rFhGST-
S1 immunised and Quil A control group. However, a high
individual variability was recorded, particularly in the vaccinated
group also reported in previous trials using goats vaccinated with
alternative candidates such as cathepsin L1 [64] and Sm14 [65]. The
vaccine trial shown here using a target species with an acceptable
adjuvant may have been adversely affected by the strain of F. hepatica
used to challenge goats. Here we have shown an unusually high
infectivity rate with the strain of F. hepatica used; which we have
reported in a previous trial using goats [64]. Using an alternative
strain of F. hepatica for experimental infections in this species has given
normal infectivity rates ranging from 14% to 26.5% [65].
In the present trial it appeared that goats immunised with
rFhGST-S1, despite no variations in fluke burdens or morpho-
metrics, showed reduced gross hepatic lesions during early
infection, up to day 9 post infection, which continued to week
15 post infection where liver scores for hepatic lesions appeared
reduced for rFhGST-S1 immunised animals. These results suggest
that animals from the immunised group produced an early
response to migrating larvae that has induced some partial
protection from liver damage. The early and consistent specific
IgG response found in the present work also agrees with the results
obtained in a previous trial using naı¨ve FhGST [46]. However, in
both studies high levels of specific IgG did not induced a protective
response reducing worm burdens.
A promising aspect of producing anti-helminth vaccines is
developing multivalent vaccines. In many cases the greatest
protection from challenge is by vaccinating with a combination
of Fasciola antigens [66,67]. Therefore, based on the immunisation
with FhGST-S1 showing an early response reducing hepatica
damage, could be considered for inclusion into a multivalent
vaccine against Fasciolosis. In addition, in light of our findings
showing FhGST-S1 to be highly prominent in egg production and
the egg itself, as with previous vaccination trials [67], it will be
important to investigate the ability of eggs voided from vaccinated
animals to embryonate. The potential to reduce pasture contam-
ination by inhibiting egg embryonation, combined with the
Table 2. Results of parasitological and hepatic gross morphometric studies from vaccination.
Group Parasitological Study FEC (epg)
Gross Hepatic
Leisons Liver Scores (Number of Animals)
Fluke Burdens
Fluke Length
(mm)
Fluke Weight
(g) 12 WPI 13 WPI 7 DPI 8 DPI 9 DPI 2 (0) + (,10) ++ (10–25)
+++ (25–
50)
++++
(.50)
1 59632.5 17.363 4.462.4 82.1 96.4 26 48 89 0 2 3 2 0
2 55.2612.4 16.863 4.663.1 100 110.7 85 165 172 0 1 2 3 0
Group 1 (goats immunised with recombinant FhGST-S1) and Group 2 (infected control group immunised with Quil A only). Liver scores were recorded at necropsy 15
wpi. WPI – Weeks post infection. DPI – Days post infection.
doi:10.1371/journal.pntd.0001666.t002
Figure 7. The effects of vaccination with rFhGST-S1 or Quil A. A) Photomicrograph of the liver from the Quil A immunised group showing an
area of coagulative necrosis (N) surrounded by scarce inflammatory infiltration (arrows) with occasional eosinophils. B) Photomicrograph of the liver
from the rFhGST-S1 immunised group showing a coagulative necrotic area (N) associated to numerous eosinophils (E). Both images haematoxylin
and eosin stained. Both bar represent 100 mm.
doi:10.1371/journal.pntd.0001666.g007
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demonstrated reduction in liver damage, warrants further
exploration using rFhGST-S1 as a vaccine candidate.
In summary, we have further promoted the concept that
FhGST-S1 clearly demonstrates key host-parasite roles in synthe-
sising PGs and stimulating PG release from host innate immune
cells. In addition we have shown FhGST-S1 to be a key protein for
detoxification, which may well be involved in TCBZ response. In
line with current vaccine development theory we have shown
FhGST-S1 to have multi-functional roles in the liver fluke
physiology. Furthermore, we have shown FhGST-S1 to be
expressed across ontogenic stages, localised to the fluke surface,
and to the egg, both characteristics vital for vaccine development
and success. Whilst no protection from fluke burden was seen in
trials, the inclusion of rFhGST-S1 as a multivalent vaccine
component should be investigated. However, it is important to
fully characterise the host immune response during the early stages
post-infection to better understand the mechanism mediating an
effective host response. This will be essential to improve any future
vaccine formulation.
[36,51,68–71] Table 2 Refs.
Supporting Information
Figure S1 Multiple sequence alignment and neighbour-
joining phylogenetic tree across seven species-indepen-
dent classes of GSTs. A) Alignment of the sigma class GSTs of
trematodes shows the extent of identity and similarity across this
class of GSTs. Boxed residues indicate complete identity between
all sequences. Residues shaded in grey indicate conserved residues.
B) Neighbour-joining tree placing mammalian and trematode
GSTs within the same broad Sigma class. A distinct separation of
clusters within this Sigma class is observed as with the recently
reclassified ‘Nu’ class of GSTs from nematodes [49]. Sequences
were aligned via the ClustalW program [29] in BioEdit Sequence
Alignment Editor version 7.0.5.2. [30]. Phylogenetic neighbour-
joining bootstrap trees were produced and viewed within TREE-
VIEW [33]. Key to sequences in 1a and 1b. Xenopus laevis;
Fhep49c06_omega Fasciola hepatica; Fhep54b04_omega Fasciola
hepatica; O09131_GSTO1_MUS Mus musculus; O35543_PTGD2-
lowbar;RAT Rattus norvegicus; O60760_PTGD2_HOMO Homo
sapiens; O73888_PTGD2_GGAL Gallus gallus; O97096_GST_
CLOSI Clonorchis sinensis; P08263_GSTA1_HOMO Homo sapiens;
P08515_GSTM_SCHJA Schistosoma japonicum; P09488_GSTM1.1
_HOMO Homo sapiens; P09792_GST28_SCHMA Schistosoma
mansoni; P10299_GSTP1_CE Caenorhabditis elegans; P19157_
GSTP1_MUS Mus musculus; P20432_GSTT1_DROME Drosophila
melanogaster; P28801_GSTP1_BOVIN Bos taurus; P30113_GST28
_SCHBO Schistosoma bovis; P30114_GST28_SCHHA Schistosoma
haematobium; P34345_GSTO_CE Caenorhabditis elegans; P35661_
GSTM_SCHMA Schistosoma mansoni; P41043_GSTS1_DROME
Drosophila melanogaster; P46436_GSTS1_ASCSU Ascaris suum;
P51781_GSTA1_PIG Sus scrofa; P78417_GSTO1_HOMO Homo
sapiens; P80031_GSTP1_PIG Sus scrofa; P91253_GSTS7_CE
Caenorhabditis elegans; Q000H8_GSTM2_PIG Sus scrofa;
Q06A71_FhGST-S1 Fasciola hepatica; Q26200_GST_PARWE
Paragonimus westermani; Q26513_GST_SCHJA Schistosoma japonicum;
Q28035_GSTA1_BOVIN Bos taurus; Q30B87_GSTM3_SHEEP
Ovis aries; Q58ET5_GSTM1_MUS Mus musculus; Q5TZY2_GSTT1
_HOMO Homo sapiens; Q5TZY3_GSTP1_HOMO Homo sapiens;
Q6IB17_GSTZ1.1_HOMO Homo sapiens; Q6P8Q0_GSTA1_MUS
Mus musculus; Q86LC0_GSTO_SCHMA Schistosoma mansoni;
Q8ISK1_GST_OPIVI Opisthorchis viverrini; Q91X50_GSTT1_MUS
Mus musculus; Q9JHF7_PTGD2_MUS Mus musculus; Q9N0V4_
GSTM1_BOVIN Bos taurus; Q9N2J6_GSTMic_SHEEP Ovis aries;
Q9N4H6_GSTZ43_CE Caenorhabditis elegans; Q9NAW7_GSTS_
HCON Haemonchus contortus; Q9TTY8_GSTP1_CAPHI Capra hircus;
Q9WVL0_GSTZ1_MUS Mus musculus; Q9XS30_GST_SHEEP
Ovis aries; XP_535659.1_PGDS_CFAM Canis familiaris. A1BNE5_
GST_CLOSI Clonorchis sinensis; AAH53774.1_GSTS1-1_XLAE
(TIF)
Table S1 Amino acid identity comparisons of FhGST-
S1 with GSTs from cytosolic classes across a variety of
taxa. Amino acid sequence comparison of FhGST-S1 with other
trematode GSTs clearly places FhGST-S1 into the Sigma class of
GSTs, with identities averaging approximately 45%. Comparison
with the most closely matching mammalian GSTs shows sequence
identities averaging only approximately 28%. PTGD – Prosta-
glandin D synthase; Mic -Microsomal.
(XLS)
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